ArticleDiscover oncology2025

Integrated analysis of single-cell and bulk RNA sequencing identifies GSTM4 as a tumor suppressor and prognostic biomarker in breast cancer.

Zhen Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.